Top

Gepubliceerd in:

2008 | OriginalPaper | Hoofdstuk

15 Nieuwe ontwikkelingen in oraal biochemisch onderzoek

Auteur : Prof. dr. A. van Nieuw Amerongen

Gepubliceerd in: Speeksel, speekselklieren en mondgezondheid

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Moleculairbiologische technieken zoals de recombinant-DNA-techniek en genklonering worden steeds vaker routinematig gebruikt, voor onder andere productie van humane eiwitten zoals insuline en groeihormoon, en voor de ontwikkeling van veilige vaccins. Synthese van glycoproteïnen met deze methode is echter nog altijd een groot probleem. Voor de synthese van kleine (niet-geglycosyleerde) eiwitten en peptiden is organisch-chemische synthese een goed alternatief. In principe kan met deze techniek elk gewenst eiwitdomein in relatief grote hoeveelheden worden gesynthetiseerd. Organisch-chemisch synthese van peptiden is een belangrijk hulpmiddel bij onderzoek naar de structuur-functierelatie van eiwitten. Daarnaast biedt deze techniek de mogelijkheid tot grootschalige synthese van peptiden voor biomedische toepassingen.

De nieuwe ontwikkelingen op het gebied van de celbiologie (onder andere weefselregeneratie, stamcelonderzoek, gentransfer en micro-arraytechniek) zijn veelbelovend. Hierdoor kunnen toepassingen op onder andere het terrein van weefselherstel en de vroege diagnostiek van maligniteiten op korte termijn worden verwacht.

vorige hoofdstuk 14 Creviculaire vloeistof

volgende hoofdstuk 16 Speekselklieraandoeningen en speeksel

Amado F.M.L., R.M.P. Vitorino, P.M.D.N. Domingues, M.J.C. Lobo en J.A.R. Duarte. Analysis of the human saliva proteome. Expert Rev. Proteomics 2, (2005)521–539.PubMedCrossRef

Auerswald E.A., G. Genenger, I. Assfalg-Machleidt, J. Kos en W. Bode. Synthesis of a (desSer 1 - Ile29 - Leu 89) chicken cystatin gene, expression in E. coli as fusion protein and its isolation. FEBS Letters, 243, (1989)186–192.PubMedCrossRef

Barrett A.J. Cystatin, the egg white inhibitor of cysteine proteinases. Methods Enzymology 80, (1981)771–778.

Baum B.J. en B.C. O’Connell. In vivo gene transfer to salivary glands. Crit. Rev. Oral Biol. Med. 10, (1999)276–283.PubMedCrossRef

Baum B.J., R.B. Wellner en C. Zheng. Gene transfer to salivary glands. Int. Rev. Cytology 213, (2002)93–146.CrossRef

Bikker F.J., A.J.M. Ligtenberg, K. Nazmi, E.C.I. Veerman, W. van ’t Hof, J.G.M. Bolscher, e.a. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J. Biol. Chem. 277, (2002) 32109–32115.PubMedCrossRef

Blankenvoorde M.F.J., Y.M.C, Henskens, G.A. van der Weijden, P.A.M. van den Keijbus, E.C.I. Veerman en A. van Nieuw Amerongen. Cystatin A in gingival crevicular fluid of periodontal patients. J. Periodont. Res. 32, (1997)583–588.PubMedCrossRef

Blankenvoorde M.F.J., W. van ’t Hof, E. Walgreen-Weterings, T.J.M. van Steenbergen, E.C.I. Veerman, H.S. Brand, e.a. Cystatins and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. Biol. Chem. 379, (1998)1371–1375.PubMed

Bobek L.A., A. Aguirre en M.J. Levine. Human salivary cystatin S. Cloning, sequence analysis, hybridization in situ and immunocytochemistry. Biochem. J. 278, (1991)627–635.PubMedCentralPubMed

Bobek L.A., X. Wang en M.J. Levine. Efficient production of biologically active human salivary cystatins in Escherichia coli. Gene 123, (1993a)203–210.PubMedCrossRef

Bobek L.A., H. Tsai, A.R. Biesbroek en M.J. Levine. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J. Biol. Chem. 268, (1993b)20563–20569.PubMed

Bolstad A.I. en R. Jonsson. Gene therapeutics in SjÖgren’s syndrome. Expert Opin. Biol. Ther. 5, (2005)763–772.PubMedCrossRef

Cohen R.E., A. Aguirre, M.E. Neiders, M.J. Levine, P.C. Jones, M.S. Reddy, e.a. Immunochemistry of high molecular-weight human salivary mucin. Archs Oral Biol. 35, (1990)127–136.CrossRef

Cohen R.E., A. Aguirre, M.E. Neiders, M.J. Levine, P.C. Jones, M.S. Reddy, e.a. Immunochemistry and immunogenicity of low molecular weight human salivary mucin. Archs Oral Biol. 36, (1991)347–356.CrossRef

Colella R., Y. Sakaguchi, H. Nagase en J.W.C. Bird. Chicken egg white cystatin - Molecular cloning, nucleotide sequence, and tissue distribution. J. Biol. Chem. 264, (1989)17164–17169.PubMed

Coppes R.P., R. Licht, P.K. Wierenga, H.H. Kampinga en G. de Haan. Recovery of radiation-induced deterioration of salivary gland morphology after transplantation with bone marrow derived stem cells, Int. J. Radiat. Oncol. Biol. Phys. 55, (2003) 491.

Fackelman K.A. Bloodsuckers reconsidered. Science News 139, (1991)172–173.CrossRef

Fong D., T. Kartasova, F. Sloane en M.M. Chan. Bacterial expression of human cysteine proteinase inhibitor Stefin A. FEBS Letters, 257, (1989)55–58.PubMedCrossRef

Gardell S.J., D.R. Ramjit, I.I. Stabilito, T. Fujita, J.J. Lynch, G.C. Cuca, e.a. Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits. Circulation 84, (1991)244–253.PubMedCrossRef

Ghafouri B., C. Tagesson en M. Lindahl. Mapping of proteins in human saliva using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 3, (2003)1003–1015.PubMedCrossRef

Groenink J., E. Walgreen-Weterings, W. van ’t Hof, E.C.I. Veerman en A. van Nieuw Amerongen. Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol. Lett. 179, (1999)217–222.PubMedCrossRef

Grubb A., M. Abrahamson, I. Olafsson, J. Trojnar, R. Kasprzykowska, F. Kasprzykowski, e.a. Synthesis of cysteine proteinase inhibitors structurally based on the proteinase interacting N-terminal region of human cystatin-C. Biol. Chem. Hoppe-Seyler 371, (1990)137–144.PubMedCrossRef

Guo T., P.A. Rudnick, W. Wang, C.S. Lee, D.L. Devoe en B.M. Balgley. Characterization of the human salivary proteome by capillary isoelectric focusing/ nanoreversed-phase liquid chromatography coupled with ESI-tandem MS. J. Proteome Res. 5, (2006)1469–1478.PubMedCrossRef

Hall A., M. Abrahamson, A. Grubb, J. Trojnar, P. Kania, R. Kasprzykowska, e.a. Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length. J. Enzyme Inhib. 6, (1992)113–123.PubMedCrossRef

Helmerhorst E.J. Design and characterization of antimicrobial peptides base don salivary histatins. Dissertatie, 1999. Vrije Universiteit, Amsterdam.

Helmerhorst E.J., W. van ’t Hof, E.C.I. Veerman, I. Simoons-Smit en A. van Nieuw Amerongen. Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem. J. 326, (1997)39–45.PubMedCentralPubMed

Helmerhorst E.J., I.M. Reijnders, W. van ’t Hof, I. Simoons-Smit, E.C.I. Veerman en A. van Nieuw Amerongen. Amphotericin B- and fluconazoleresistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob. Agents Chemother. 43, (1999a)702–704.PubMedCentralPubMed

Helmerhorst E.J., P. Breeuwer, W. van ’t Hof, E. Walgreen-Weterings, L.C. Oomen, E.C.I. Veerman, e.a. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 274, (1999b)7286–7291.PubMedCrossRef

Helmerhorst E.J., M.P. Murphy, R.F. Troxler en F.G. Oppenheim. Characterization of the mitochondrial respiratory pathways in Candida albicans. Biochim. Biophys. Acta 1556, (2002)73–80.PubMedCrossRef

Henskens Y.M.C., U. van der Velden, E.C.I. Veerman en A. van Nieuw Amerongen. Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J. Periodont. Res. 28, (1993)43–48.PubMedCrossRef

Hertog A.L. den, J. van Marle, E.C.I. Veerman, M. Valentijn-Benz, K. Nazmi, H. Kalay, C.H. Grün, e.a. The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol. Chem. 387, (2006)1495–1502.

Hirtz C., F. Chevalier, D. Centeno, V. Rofidal, J.-C. Egea, M. Rossignol, e.a. MS characterization of multiple forms of alpha-amylase in human saliva. Proteomics 5, (2005)4597–4607.PubMedCrossRef

HofW. van ’t, E.C.I. Veerman, E.J. Helmerhorst en A. van Nieuw Amerongen. Antimicrobial peptides: properties and applicability. Biol. Chem. 382, (2001)597–619.CrossRef

Hof W. van ’t, M.F.J. Blankenvoorde, E.C.I. Veerman en A. van Nieuw Amerongen. The salivary lipocalin Von Ebner’s gland protein is a cysteine proteinase inhibitor. J. Biol. Chem. 272, (1997)1837–1841.CrossRef

Hu S., J.A. Loo en D.T. Wong. Human saliva proteome analysis. Ann. N. Y. Acad. Sci. 1098, (2007)323–329.PubMedCrossRef

Jürgens M. en M. Schrader. Peptidomic approaches in proteomic research. Curr. Opin. Mol. Therap. 4, (2002)236–241.

Kraan M.I.A. van der, K. Nazmi,W. van ’t Hof, A. van Nieuw Amerongen, E.C.I. Veerman en J.G.M. Bolscher. Distinct bactericidal activities of bovine lactoferrin peptides LF-ampin 268-284 and LF-ampin 265-284: Asp-Leu-Ile sequence makes the difference. Biochem. Cell Biol. 84, (2006)358–362.PubMedCrossRef

Levine M.J., M.S. Reddy, L.A. Tabak, R.E. Loomis, E.J. Bergey, P.C. Jones, e.a. Structural aspects of salivary glycoproteins. J. Dent. Res. 66, (1987)436–441.PubMedCrossRef

Levine M.J., A. Aguirre, M.N. Hatton en L.A. Tabak. Artificial salivas: present and future. J. Dent. Res. 66, (1987)693–698.PubMedCrossRef

Li Y., X. Zhou, M.A.R. St. John en W.T. Wong. RNA profiling of cell-free saliva using microarray technology. J. Dent. Res. 83, (2004)199–203.

Ligtenberg A.J.M., E. Walgreen-Weterings, E.C.I. Veerman, J.J. de Soet, J. de Graaff en A. van Nieuw Amerongen. Influence of saliva on the aggregation and adherence of Streptococcus gordonii HG 222. Infect. Immun. 60, (1992)3878–3884.PubMedCentralPubMed

Loomis R.E., A. Prakobphol, M.J. Levine, M.S. Reddy en P.C. Jones. Biochemical and biophysical comparison of two mucins from human submandibular- sublingual saliva. Archs Biochem. Biophys. 258, (1987)452–464.CrossRef

Mackay B.J., J.J. Pollock, V.J. Iacono en B.J. Baum. Isolation of milligram quantities of a group of histidine-rich polypeptides from human parotid saliva. Infect. Immun. 44, (1984)688–694.PubMedCentralPubMed

Mandel I.D. A contemporary view of salivary research. Crit. Rev. Oral Biol. Med. 4, (1993)599–604.PubMed

Messana I., R. Inzitari, C. Fanali, T. Cabras en M. Castagnola. Facts and artifacts in proteomics of body fluids. What proteomics of salvia is telling us? J. Seperation Sci. 31, (2008)1948–1963.CrossRef

Nikawa T., T. Towatari, Y. Ike en N. Katunuma. Studies on the reactive site of the cystatin superfamily using recombinant cystatin A mutants - Evidence that the QVVAG region is not essential for cysteine proteinase inhibitory activities. FEBS Letters 255, (1989)309–314.PubMedCrossRef

Nishikata M., T. Kanehira, H. Oh, H. Tani, M. Tazaki en Y. Kuboki. Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis. Biochem. Biophys. Res. Comm. 174, (1991)625–630.PubMedCrossRef

O’Connell B.C., C. Zheng, D. Jacobson-Kram en B.J. Baum. Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult rats. J. Oral Pathol. Med. 32, (2003)414–421.PubMedCrossRef

Oppenheim F.G., T. Xu, F.M. McMillian, S.M. Levitz, R.D. Diamond, G.D. Offner, e.a. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem. 263, (1988)7472–7477.PubMed

Papagianni M. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function and applications. Biotechn. Adv. 21, (2003)465–499.CrossRef

Prakobphol A., M.J. Levine, L.A. Tabak en M.S. Reddy. Purification of a low-molecular-weight, mucin-type glycoprotein from human submandibular- sublingual saliva. Carbohydr. Res. 108, (1982)111–122.PubMedCrossRef

Reijden W.A. van der, M.J. Buijs, J.J.M. Damen, E.C.I. Veerman, J.M. ten Cate en A. van Nieuw Amerongen. Influence of polymers for use in artificial saliva substitutes on de- and remineralization of enamel in vitro. Caries Res. 31, (1997)216–223.PubMedCrossRef

Ruissen A.L.A., J. Groenink, E.J. Helmerhorst, E. Walgreen-Weterings, W. van ’t Hof, E.C.I. Veerman en A. van Nieuw Amerongen. Effects of histatin 5 and derived peptides on Candida albicans. Biochem. J. 356, (2001) 361–368.PubMedCentralPubMedCrossRef

Ruissen A.L.A., J. Groenink, C.H. Lommerse, W. van ’t Hof, E.C.I. Veerman en A. van Nieuw Amerongen. Effects of carbohydrate polymers applicable in saliva substitutes on the anti-Candida activity of a histatin-derived peptide. Archs Oral Biol. 47, (2002)749–756.CrossRef

Santarpia R.P., M.I. Cho en J.J. Pollock. Parameters affecting the inhibition of Candida albicans GDH 2023 and GRI 2773 blastospore viability by purified synthetic salivary histidine-rich polypeptides. Oral Microb. Immunol. 5, (1990)226–232.CrossRef

Schipper R.G., E. Silletti en M.H. Vingerhoeds. Saliva as research material: Biochemical, physicochemical and practical aspects. Archs Oral Biol. 52, (2007)1114–1135.CrossRef

Spek J.C. van der, G.D. Offner, R.F. Troxler en F.G. Oppenheim. Molecular cloning of human submandibular histatins. Archs Oral Biol. 35, (1990)137–143.CrossRef

Strietzel F.P., R. Martin-Granizo, S. Fedele, L. Lo Russo, M. Mignogna, P.A. Reichart, e.a. Electrostimulating device in the management of xerostomia. Oral Dis. 13, (2007)206–213.PubMedCrossRef

Tabak L.A. en W.H. Bowen. Roles of saliva (pellicle), diet, and nutrition on plaque formation. J. Dent. Res., 68, (1989)1560–1566.

Veerman E.C.I., M. Valentijn-Benz en A. van Nieuw Amerongen. Isolation of high molecular weight mucins from human whole saliva by ultracentrifugation. J. Biol. Buccale 17, (1989)307–312.PubMed

Veerman E.C.I., M. Valentijn-Benz, P.A.M. van den Keijbus, W.M. Rathman, J.K. Sheehan en A. van Nieuw Amerongen. Immunochemical analysis of human salivary mucins using monoclonal antibodies. Archs Oral Biol. 36, (1991)923–932.CrossRef

Veerman E.C.I., P.A.M. van den Keijbus, M. Valentijn-Benz en A. van Nieuw Amerongen. Isolation of different high molecular weight mucin species from human whole saliva. Biochem. J. 283, (1992)807–811.PubMedCentralPubMed

Voutetakis, I. Bossis, M.R. Kok, W. Zhang, J. Wang, A.P. Cotrim, e.a. Salivary A. glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J. Endocrinol. 185, (2005)363–372.PubMedCrossRef

Waxman L., D.E. Smith, K.E. Arcuri en G.P. Vlasuk. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 248, (1990)593–596.PubMedCrossRef

Yamano S., L.-Y. Huang, C. Ding, J.A. Chiorini, C.M. Goldsmith, R.B. Wellner, e.a. Recombinant adenoassociated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Human Gen. Ther. 13, (2002)287–298.CrossRef

Titel: 15 Nieuwe ontwikkelingen in oraal biochemisch onderzoek
Auteur: Prof. dr. A. van Nieuw Amerongen
Uitgeverij: Bohn Stafleu van Loghum
Boek: Speeksel, speekselklieren en mondgezondheid
Print ISBN: 978-90-313-5173-2

Elektronisch ISBN: 978-90-313-6317-9

Copyright: 2008
DOI: https://doi.org/10.1007/978-90-313-6317-9_15

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen